SBIO (ALPS Medical Breakthroughs ETF) Stock Analysis - Insider Trades

ALPS Medical Breakthroughs ETF (SBIO) is a publicly traded the market company. As of May 21, 2026, SBIO trades at $58.43 with a market cap of $0 and a P/E ratio of 0.00. SBIO moved +0.00% today. Year to date, SBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SBIO stock inside the company?

Rallies tracks SBIO insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

SBIO Key Metrics

Key financial metrics for SBIO
MetricValue
Price$58.43
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume114.58K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

SBIO Analyst Consensus

SBIO analyst coverage data. Average price target: $0.00.

Common questions about SBIO

Who is trading SBIO stock inside the company?
Rallies tracks SBIO insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for SBIO?
Yes. Rallies tracks SBIO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SBIO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SBIO. It does not provide personalized investment advice.
SBIO

SBIO